{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:46:18Z","timestamp":1792025178829,"version":"4.4.0"},"reference-count":146,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Despite their histologically benign classification, craniopharyngiomas (CPs) are clinically aggressive neoplasms that often present with local invasion and significant morbidity. While recent insights into the molecular characteristics of CP have prompted exciting advances in neoadjuvant targeted therapeutics, current diagnostic methods still require tissue samples obtained invasively through resection or surgical biopsy. However, novel diagnostic approaches, such as imaging-based diagnostics and liquid biopsies, are emerging options that support a noninvasive paradigm shift in CP management. This review summarizes current and emerging diagnostic approaches for CP and discusses the challenges and progress toward maximizing the potential of noninvasive CP management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>The authors conducted a narrative review of peer-reviewed literature from the past 20 years. Key domains included CP; histopathological and molecular diagnostics; radiomics and AI; and liquid biopsy development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      The current standard diagnostic method for CP is pathological tissue confirmation obtained through invasive surgical biopsy or resection. Radiomics and AI-based \"imaging biopsy\" approaches show strong potential for noninvasive CP differentiation. However, despite promising accuracy in retrospective studies, clinical translation remains limited due to small and heterogeneous datasets, nonstandardized imaging pipelines, limited interpretability, and lack of prospective multicenter validation. Liquid biopsy represents another emerging minimally invasive alternative. Although\n                      <jats:italic>BRAF<\/jats:italic>\n                      V600E has been detected in plasma and CSF in isolated reports, the evidence remains sparse, and current assays may lack the sensitivity required to reliably detect CP driver mutations. Further research and improvement of technical limitations are needed to advance this promising field of noninvasive diagnostics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Diagnostic innovation for CP is accelerating, with radiomics-based models and liquid biopsies offering promising alternatives to invasive tissue sampling. However, widespread clinical adoption has been hindered by a lack of high-quality validation. Multicenter studies, larger datasets, and harmonized protocols are essential to integrate these emerging tools into clinical practice and improve diagnostic management for CP. A future noninvasive treatment schema that combines advances in both diagnostic and therapeutic strategies is proposed for papillary CP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2026.2.focus251109","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:01:00Z","timestamp":1779840060000},"page":"E12","source":"Crossref","is-referenced-by-count":1,"title":["Evolving approaches to craniopharyngioma diagnosis"],"prefix":"10.3171","volume":"60","author":[{"given":"Iris P.","family":"van Mullem","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston;"},{"name":"Department of Neurosurgery, Leiden University Medical Centre, Leiden, Zuid-Holland, The Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel A.","family":"Wood","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston;"},{"name":"T. H. Chan School of Medicine, UMass Chan Medical School, Worcester, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye Rim","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Martinez","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston;"},{"name":"Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Rapalino","sequence":"additional","affiliation":[{"name":"Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Conner","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy J.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston;"},{"name":"Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, Florida;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie P.","family":"Fehnel","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Boston Children\u2019s Hospital, Harvard Medical School, Boston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred G.","family":"Barker","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla K.","family":"Brastianos","sequence":"additional","affiliation":[{"name":"Divisions of Neuro-Oncology and Hematology\/Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela S.","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"1","key":"b1","series-title":"Nat Rev Dis Primers","first-page":"75","article-title":"Craniopharyngioma","volume":"5","author":"M\u00fcller HL","year":"2019","unstructured":"M\u00fcller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S. Craniopharyngioma. Nat Rev Dis Primers. 2019;5(1):75. doi:10.1038\/s41572-019-0125-9"},{"issue":"4","key":"b2","series-title":"Neurosurgery","first-page":"631","article-title":"Adult craniopharyngioma: case series, systematic review, and meta-analysis","volume":"83","author":"Dandurand C","year":"2018","unstructured":"Dandurand C, Sepehry AA, Asadi Lari MH, Akagami R, Gooderham P. Adult craniopharyngioma: case series, systematic review, and meta-analysis. Neurosurgery. 2018;83(4):631\u2013641. doi:10.1093\/neuros\/nyx570"},{"issue":"3","key":"b3","series-title":"Endocr Rev","first-page":"518","article-title":"Contemporary biological insights and clinical management of craniopharyngioma","volume":"44","author":"Apps JR","year":"2023","unstructured":"Apps JR, Muller HL, Hankinson TC, Yock TI, Martinez-Barbera JP. Contemporary biological insights and clinical management of craniopharyngioma. Endocr Rev. 2023;44(3):518\u2013538. doi:10.1210\/endrev\/bnac035"},{"issue":"11","key":"b4","series-title":"Heliyon","first-page":"e32112","article-title":"Craniopharyngioma: a comprehensive review of the clinical presentation, radiological findings, management, and future perspective","volume":"10","author":"Alboqami MN","year":"2024","unstructured":"Alboqami MN, Khalid S Albaiahy A, Bukhari BH,  Craniopharyngioma: a comprehensive review of the clinical presentation, radiological findings, management, and future perspective. Heliyon. 2024;10(11):e32112. doi:10.1016\/j.heliyon.2024.e32112"},{"issue":"2","key":"b5","series-title":"Nat Genet","first-page":"161","article-title":"Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas","volume":"46","author":"Brastianos PK","year":"2014","unstructured":"Brastianos PK, Taylor-Weiner A, Manley PE,  Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet. 2014;46(2):161\u2013165. doi:10.1038\/ng.2868"},{"issue":"6","key":"b6","series-title":"Acta Neuropathol","first-page":"589","article-title":"Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region","volume":"109","author":"Buslei R","year":"2005","unstructured":"Buslei R, Nolde M, Hofmann B,  Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol. 2005;109(6):589\u2013597. doi:10.1007\/s00401-005-1004-x"},{"issue":"5","key":"b7","series-title":"Pituitary","first-page":"544","article-title":"Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor","volume":"19","author":"Aylwin SJB","year":"2016","unstructured":"Aylwin SJB, Bodi I, Beaney R. Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor. Pituitary. 2016;19(5):544\u2013546. doi:10.1007\/s11102-015-0663-4"},{"issue":"4","key":"b8","series-title":"Pituitary","first-page":"482","article-title":"Dabrafenib as a diagnostic and therapeutic strategy for the non-surgical management of papillary craniopharyngioma","volume":"26","author":"Lin AL","year":"2023","unstructured":"Lin AL, Tabar V, Young RJ, Geer EB. Dabrafenib as a diagnostic and therapeutic strategy for the non-surgical management of papillary craniopharyngioma. Pituitary. 2023;26(4):482\u2013487. doi:10.1007\/s11102-023-01339-y"},{"issue":"2","key":"b9","series-title":"N Engl J Med","first-page":"118","article-title":"BRAF-MEK inhibition in newly diagnosed papillary craniopharyngiomas","volume":"389","author":"Brastianos PK","year":"2023","unstructured":"Brastianos PK, Twohy E, Geyer S,  BRAF-MEK inhibition in newly diagnosed papillary craniopharyngiomas. N Engl J Med. 2023;389(2):118\u2013126. doi:10.1056\/NEJMoa2213329"},{"key":"b10","series-title":"Front Oncol","first-page":"791","article-title":"Targeting IL-6 is a potential treatment for primary cystic craniopharyngioma","volume":"9","author":"Grob S","year":"2019","unstructured":"Grob S, Mirsky DM, Donson AM,  Targeting IL-6 is a potential treatment for primary cystic craniopharyngioma. Front Oncol. 2019;9:791. doi:10.3389\/fonc.2019.00791"},{"issue":"6","key":"b11","series-title":"Ann Endocrinol (Paris)","first-page":"727","article-title":"First evidence of anti-VEGF efficacy in an adult case of adamantinomatous craniopharyngioma: case report and illustrative review","volume":"84","author":"De Rosa A","year":"2023","unstructured":"De Rosa A, Calvanese F, Ducray F,  First evidence of anti-VEGF efficacy in an adult case of adamantinomatous craniopharyngioma: case report and illustrative review. Ann Endocrinol (Paris). 2023;84(6):727\u2013733. doi:10.1016\/j.ando.2023.10.003"},{"issue":"3","key":"b12","series-title":"Pediatr Blood Cancer","first-page":"e28753","article-title":"Radiologic response to MEK inhibition in a patient with a WNT-activated craniopharyngioma","volume":"68","author":"Patel K","year":"2021","unstructured":"Patel K, Allen J, Zagzag D,  Radiologic response to MEK inhibition in a patient with a WNT-activated craniopharyngioma. Pediatr Blood Cancer. 2021;68(3):e28753. doi:10.1002\/pbc.28753"},{"issue":"4","key":"b13","series-title":"Eur J Endocrinol","first-page":"R139","article-title":"Endocrine tumors: BRAF V600E mutations in papillary craniopharyngioma","volume":"174","author":"Brastianos PK","year":"2016","unstructured":"Brastianos PK, Santagata S. Endocrine tumors: BRAF V600E mutations in papillary craniopharyngioma. Eur J Endocrinol. 2016;174(4):R139\u2013R144. doi:10.1530\/EJE-15-0957"},{"key":"b14","series-title":"Front Endocrinol (Lausanne)","first-page":"1562942","article-title":"Recent advances in craniopharyngioma pathophysiology and emerging therapeutic approaches","volume":"16","author":"Pires de Oliveira Neto C","year":"2025","unstructured":"Pires de Oliveira Neto C, Nascimento GC, Damianse SDSP, Faria MDS. Recent advances in craniopharyngioma pathophysiology and emerging therapeutic approaches. Front Endocrinol (Lausanne). 2025;16:1562942. doi:10.3389\/fendo.2025.1562942"},{"issue":"6","key":"b15","series-title":"Neurosurg Focus","first-page":"E2","article-title":"Diagnosis and management of craniopharyngiomas in the era of genomics and targeted therapy","volume":"41","author":"Martinez-Gutierrez JC","year":"2016","unstructured":"Martinez-Gutierrez JC, D\u2019Andrea MR, Cahill DP, Santagata S, Barker FG, Brastianos PK. Diagnosis and management of craniopharyngiomas in the era of genomics and targeted therapy. Neurosurg Focus. 2016;41(6):E2. doi:10.3171\/2016.9.FOCUS16325"},{"key":"b16","series-title":"Front Neurol","first-page":"752119","article-title":"Application of artificial intelligence in diagnosis of craniopharyngioma","volume":"12","author":"Qin C","year":"2021","unstructured":"Qin C, Hu W, Wang X, Ma X. Application of artificial intelligence in diagnosis of craniopharyngioma. Front Neurol. 2021;12:752119. doi:10.3389\/fneur.2021.752119"},{"key":"b17","series-title":"World Neurosurg","first-page":"601","article-title":"Creative and innovative methods and techniques for the challenges in the management of adult craniopharyngioma","volume":"142","author":"Takami H","year":"2020","unstructured":"Takami H, Vel\u00e1squez C, Asha MJ, Oswari S, Almeida JP, Gentili F. Creative and innovative methods and techniques for the challenges in the management of adult craniopharyngioma. World Neurosurg. 2020;142:601\u2013610. doi:10.1016\/j.wneu.2020.05.173"},{"issue":"2","key":"b18","series-title":"J Clin Med","first-page":"519","article-title":"The inflammatory milieu of adamantinomatous craniopharyngioma and its implications for treatment","volume":"9","author":"Whelan R","year":"2020","unstructured":"Whelan R, Prince E, Gilani A, Hankinson T. The inflammatory milieu of adamantinomatous craniopharyngioma and its implications for treatment. J Clin Med. 2020;9(2):519. doi:10.3390\/jcm9020519"},{"key":"b19","series-title":"World Neurosurg","first-page":"124414","article-title":"Targeted therapy for recurrent and refractory papillary craniopharyngioma: a systematic narrative review","volume":"202","author":"Lin Y","year":"2025","unstructured":"Lin Y, Luo N, Zhang B, An W, Lin Z. Targeted therapy for recurrent and refractory papillary craniopharyngioma: a systematic narrative review. World Neurosurg. 2025;202:124414. doi:10.1016\/j.wneu.2025.124414"},{"issue":"7","key":"b20","series-title":"Head Neck","first-page":"1036","article-title":"Craniopharyngioma: a pathologic, clinical, and surgical review","volume":"34","author":"Fernandez-Miranda JC","year":"2012","unstructured":"Fernandez-Miranda JC, Gardner PA, Snyderman CH,  Craniopharyngioma: a pathologic, clinical, and surgical review. Head Neck. 2012;34(7):1036\u20131044. doi:10.1002\/hed.21771"},{"key":"b21","article-title":"Central Nervous System Tumours: WHO Classification of Tumours","year":"2021","unstructured":"Central Nervous System Tumours: WHO Classification of Tumours. 5th ed. World Health Organization;2021."},{"key":"b22","series-title":"F1000Res","first-page":"1202","article-title":"Recent advances in molecular pathology of craniopharyngioma","volume":"6","author":"Larkin S","year":"2017","unstructured":"Larkin S, Karavitaki N. Recent advances in molecular pathology of craniopharyngioma. F1000Res. 2017;6:1202. doi:10.12688\/f1000research.11549.1"},{"issue":"5","key":"b23","series-title":"Acta Neuropathol","first-page":"757","article-title":"Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK\/ERK pathway as a novel therapeutic target","volume":"135","author":"Apps JR","year":"2018","unstructured":"Apps JR, Carreno G, Gonzalez-Meljem JM,  Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK\/ERK pathway as a novel therapeutic target. Acta Neuropathol. 2018;135(5):757\u2013777. doi:10.1007\/s00401-018-1830-2"},{"issue":"5","key":"b24","series-title":"Neuro Oncol","first-page":"1180","article-title":"Molecular subtypes of adamantinomatous craniopharyngiomas","volume":"27","author":"An W","year":"2025","unstructured":"An W, Li S, An Y, Lin Z. Molecular subtypes of adamantinomatous craniopharyngiomas. Neuro Oncol. 2025;27(5):1180\u20131192. doi:10.1093\/neuonc\/noaf030"},{"issue":"18","key":"b25","series-title":"ACS Chem Neurosci","first-page":"3347","article-title":"Transcription factor GLI1 induces IL-6-mediated inflammatory response and facilitates the progression of adamantinomatous craniopharyngioma","volume":"14","author":"Zhao J","year":"2023","unstructured":"Zhao J, Yang Y, Pan Y,  Transcription factor GLI1 induces IL-6-mediated inflammatory response and facilitates the progression of adamantinomatous craniopharyngioma. ACS Chem Neurosci. 2023;14(18):3347\u20133356. doi:10.1021\/acschemneuro.3c00031"},{"issue":"5","key":"b26","series-title":"J Neurosurg","first-page":"1473","article-title":"Do craniopharyngioma molecular signatures correlate with clinical characteristics?","volume":"128","author":"Omay SB","year":"2018","unstructured":"Omay SB, Chen YN, Almeida JP,  Do craniopharyngioma molecular signatures correlate with clinical characteristics?. J Neurosurg. 2018;128(5):1473\u20131478. doi:10.3171\/2017.1.JNS162232"},{"issue":"4","key":"b27","series-title":"Brain Tumor Pathol","first-page":"130","article-title":"Comprehensive molecular characterization of craniopharyngiomas using whole transcriptome and spatial transcriptomics approaches","volume":"42","author":"Kert \u0160","year":"2025","unstructured":"Kert \u0160, Matja\u0161i\u010d A, Pi\u017eem J,  Comprehensive molecular characterization of craniopharyngiomas using whole transcriptome and spatial transcriptomics approaches. Brain Tumor Pathol. 2025;42(4):130\u2013142. doi:10.1007\/s10014-025-00509-z"},{"issue":"6","key":"b28","series-title":"Pituitary","first-page":"905","article-title":"Targeted BRAF and CTNNB1 next-generation sequencing allows proper classification of nonadenomatous lesions of the sellar region in samples with limiting amounts of lesional cells","volume":"18","author":"Marucci G","year":"2015","unstructured":"Marucci G, de Biase D, Zoli M,  Targeted BRAF and CTNNB1 next-generation sequencing allows proper classification of nonadenomatous lesions of the sellar region in samples with limiting amounts of lesional cells. Pituitary. 2015;18(6):905\u2013911. doi:10.1007\/s11102-015-0669-y"},{"issue":"3","key":"b29","series-title":"JAMA Oncol","first-page":"317","article-title":"Molecular testing for the World Health Organization Classification of Central Nervous System Tumors: a review","volume":"11","author":"Horbinski C","year":"2025","unstructured":"Horbinski C, Solomon DA, Lukas RV,  Molecular testing for the World Health Organization Classification of Central Nervous System Tumors: a review. JAMA Oncol. 2025;11(3):317\u2013328. doi:10.1001\/jamaoncol.2024.5506"},{"issue":"1","key":"b30","series-title":"Signal Transduct Target Ther","first-page":"3","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu J","year":"2022","unstructured":"Liu J, Xiao Q, Xiao J,  Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7(1):3. doi:10.1038\/s41392-021-00762-6"},{"issue":"Supplement_5","key":"b31","series-title":"Neuro Oncol","first-page":"v127","article-title":"CTNI-10. A phase 1\/2 trial of FOG-001, a first-in-class direct \u03b2-Catenin:TCF4 inhibitor: safety and preliminary antitumor activity in adamantinomatous craniopharyngioma (ACP) patients","volume":"27","author":"Papadopoulos KP","year":"2025","unstructured":"Papadopoulos KP, Brastianos PK, Cecchini M,  CTNI-10. A phase 1\/2 trial of FOG-001, a first-in-class direct \u03b2-Catenin:TCF4 inhibitor: safety and preliminary antitumor activity in adamantinomatous craniopharyngioma (ACP) patients. Neuro Oncol. 2025;27(Supplement_5):v127. doi:10.1093\/neuonc\/noaf201.0507"},{"issue":"4","key":"b32","series-title":"Endocrinol Metab Clin North Am","first-page":"703","article-title":"Pathogenesis of craniopharyngiomas and targeted approaches to therapy","volume":"54","author":"Gritsch S","year":"2025","unstructured":"Gritsch S, Brastianos PK. Pathogenesis of craniopharyngiomas and targeted approaches to therapy. Endocrinol Metab Clin North Am. 2025;54(4):703\u2013714. doi:10.1016\/j.ecl.2025.06.006"},{"key":"b33","series-title":"Front Oncol","first-page":"735778","article-title":"Diagnostic value of non-contrast CT in cerebrospinal fluid leakage after endoscopic transnasal surgery for sellar and suprasellar tumors","volume":"11","author":"Gao W","year":"2021","unstructured":"Gao W, Wang X, Fang Y,  Diagnostic value of non-contrast CT in cerebrospinal fluid leakage after endoscopic transnasal surgery for sellar and suprasellar tumors. Front Oncol. 2021;11:735778. doi:10.3389\/fonc.2021.735778"},{"issue":"1","key":"b34","series-title":"Clin Epigenetics","first-page":"87","article-title":"Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluid","volume":"16","author":"Cornelli L","year":"2024","unstructured":"Cornelli L, Van Paemel R, Ferro Dos Santos MR,  Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluid. Clin Epigenetics. 2024;16(1):87. doi:10.1186\/s13148-024-01696-w"},{"issue":"4","key":"b35","series-title":"Mod Pathol","first-page":"596","article-title":"Cross-reactivity of the BRAF VE1 antibody with epitopes in axonemal dyneins leads to staining of cilia","volume":"28","author":"Jones RT","year":"2015","unstructured":"Jones RT, Abedalthagafi MS, Brahmandam M,  Cross-reactivity of the BRAF VE1 antibody with epitopes in axonemal dyneins leads to staining of cilia. Mod Pathol. 2015;28(4):596\u2013606. doi:10.1038\/modpathol.2014.150"},{"issue":"6","key":"b36","series-title":"Am J Clin Pathol","first-page":"811","article-title":"VE1 antibody immunoreactivity in normal anterior pituitary and adrenal cortex without detectable BRAF V600E mutations","volume":"141","author":"Mordes DA","year":"2014","unstructured":"Mordes DA, Lynch K, Campbell S,  VE1 antibody immunoreactivity in normal anterior pituitary and adrenal cortex without detectable BRAF V600E mutations. Am J Clin Pathol. 2014;141(6):811\u2013815. doi:10.1309\/AJCP37TLZLTUAOJL"},{"issue":"1","key":"b37","series-title":"Neurosurg Rev","first-page":"41","article-title":"Histopathological and molecular predictors of growth patterns and recurrence in craniopharyngiomas: a systematic review","volume":"43","author":"Coury JR","year":"2020","unstructured":"Coury JR, Davis BN, Koumas CP, Manzano GS, Dehdashti AR. Histopathological and molecular predictors of growth patterns and recurrence in craniopharyngiomas: a systematic review. Neurosurg Rev. 2020;43(1):41\u201348. doi:10.1007\/s10143-018-0978-5"},{"issue":"1","key":"b38","series-title":"J Exp Clin Cancer Res","first-page":"95","article-title":"Can recurrences be predicted in craniopharyngiomas? \u03b2-catenin coexisting with stem cells markers and p-ATM in a clinicopathologic study of 45cases","volume":"36","author":"Guadagno E","year":"2017","unstructured":"Guadagno E, de Divitiis O, Solari D,  Can recurrences be predicted in craniopharyngiomas? \u03b2-catenin coexisting with stem cells markers and p-ATM in a clinicopathologic study of 45cases. J Exp Clin Cancer Res. 2017;36(1):95. doi:10.1186\/s13046-017-0562-9"},{"issue":"12","key":"b39","series-title":"Neurochem Res","first-page":"2346","article-title":"Expression of matrix metalloproteinase-9, type IV collagen and vascular endothelial growth factor in adamantinous craniopharyngioma","volume":"36","author":"Xia Z","year":"2011","unstructured":"Xia Z, Liu W, Li S,  Expression of matrix metalloproteinase-9, type IV collagen and vascular endothelial growth factor in adamantinous craniopharyngioma. Neurochem Res. 2011;36(12):2346\u20132351. doi:10.1007\/s11064-011-0560-9"},{"issue":"7","key":"b40","series-title":"Childs Nerv Syst","first-page":"1461","article-title":"Ki67 as a prognostic factor of craniopharyngioma\u2019s recurrence in paediatric population","volume":"36","author":"Moszczy\u0144ska E","year":"2020","unstructured":"Moszczy\u0144ska E, Prokop-Piotrkowska M, Bogusz-W\u00f3jcik A, Grajkowska W, Szyma\u0144ska S, Szalecki M. Ki67 as a prognostic factor of craniopharyngioma\u2019s recurrence in paediatric population. Childs Nerv Syst. 2020;36(7):1461\u20131469. doi:10.1007\/s00381-020-04519-4"},{"issue":"24","key":"b41","series-title":"J Clin Med","first-page":"7481","article-title":"Pathological diagnosis of adult craniopharyngioma on MR images: an automated end-to-end approach based on deep neural networks requiring no manual segmentation","volume":"11","author":"Teng Y","year":"2022","unstructured":"Teng Y, Ran X, Chen B, Chen C, Xu J. Pathological diagnosis of adult craniopharyngioma on MR images: an automated end-to-end approach based on deep neural networks requiring no manual segmentation. J Clin Med. 2022;11(24):7481. doi:10.3390\/jcm11247481"},{"key":"b42","series-title":"Clin Neurol Neurosurg","first-page":"106347","article-title":"Prediction of CTNNB1 mutation status in pediatric cystic adamantinomatous craniopharyngioma by using preoperative magnetic resonance imaging manifestation","volume":"200","author":"Zhu W","year":"2021","unstructured":"Zhu W, Tang T, Yuan S, Chang B, Li S, Chen M. Prediction of CTNNB1 mutation status in pediatric cystic adamantinomatous craniopharyngioma by using preoperative magnetic resonance imaging manifestation. Clin Neurol Neurosurg. 2021;200:106347. doi:10.1016\/j.clineuro.2020.106347"},{"issue":"1","key":"b43","series-title":"Acta Med Litu","first-page":"68","article-title":"Imaging and MR spectroscopy in papillary craniopharyngioma","volume":"31","author":"Mahajan A","year":"2024","unstructured":"Mahajan A, Charan BD, Agarwal S,  Imaging and MR spectroscopy in papillary craniopharyngioma. Acta Med Litu. 2024;31(1):68\u201374. doi:10.15388\/Amed.2024.31.1.10"},{"issue":"15","key":"b44","series-title":"Cancers (Basel)","first-page":"3831","article-title":"The challenging management of craniopharyngiomas in adults: time for a reappraisal?","volume":"14","author":"Cuny T","year":"2022","unstructured":"Cuny T, Buchfelder M, Dufour H,  The challenging management of craniopharyngiomas in adults: time for a reappraisal?. Cancers (Basel). 2022;14(15):3831. doi:10.3390\/cancers14153831"},{"key":"b45","series-title":"Neoplasia","first-page":"101060","article-title":"Distinction of papillary and adamantinomatous craniopharyngioma: clinical features, surgical nuances and hypothalamic outcomes","volume":"57","author":"Yang L","year":"2024","unstructured":"Yang L, Liu Y, Wang C,  Distinction of papillary and adamantinomatous craniopharyngioma: clinical features, surgical nuances and hypothalamic outcomes. Neoplasia. 2024;57:101060. doi:10.1016\/j.neo.2024.101060"},{"issue":"1","key":"b46","series-title":"J Neurosurg","first-page":"27","article-title":"Prediction of BRAF mutation status of craniopharyngioma using magnetic resonance imaging features","volume":"129","author":"Yue Q","year":"2018","unstructured":"Yue Q, Yu Y, Shi Z,  Prediction of BRAF mutation status of craniopharyngioma using magnetic resonance imaging features. J Neurosurg. 2018;129(1):27\u201334. doi:10.3171\/2017.4.JNS163113"},{"issue":"2","key":"b47","series-title":"Neurosurgery","first-page":"204","article-title":"A clinical rule for preoperative prediction of BRAF mutation status in craniopharyngiomas","volume":"85","author":"Fujio S","year":"2019","unstructured":"Fujio S, Juratli TA, Arita K,  A clinical rule for preoperative prediction of BRAF mutation status in craniopharyngiomas. Neurosurgery. 2019;85(2):204\u2013210. doi:10.1093\/neuros\/nyy569"},{"issue":"5","key":"b48","series-title":"Neuroradiology","first-page":"1313","article-title":"Tumor features in adult papillary and adamantinomatous craniopharyngioma: neuroradiological evaluation of pituitary-hypothalamic-axis dysfunction and outcome prediction","volume":"67","author":"Calandrelli R","year":"2025","unstructured":"Calandrelli R, Pilato F, D\u2019Apolito G,  Tumor features in adult papillary and adamantinomatous craniopharyngioma: neuroradiological evaluation of pituitary-hypothalamic-axis dysfunction and outcome prediction. Neuroradiology. 2025;67(5):1313\u20131327. doi:10.1007\/s00234-025-03615-z"},{"issue":"3","key":"b49","series-title":"J Neurol Surg Rep","first-page":"e121","article-title":"Pathological and topographical classification of craniopharyngiomas: a literature review","volume":"77","author":"Lubuulwa J","year":"2016","unstructured":"Lubuulwa J, Lei T. Pathological and topographical classification of craniopharyngiomas: a literature review. J Neurol Surg Rep. 2016;77(3):e121\u2013e127. doi:10.1055\/s-0036-1588060"},{"issue":"4","key":"b50","series-title":"Eur Radiol","first-page":"2665","article-title":"Automated segmentation of craniopharyngioma on MR images using U-Net-based deep convolutional neural network","volume":"33","author":"Chen C","year":"2023","unstructured":"Chen C, Zhang T, Teng Y,  Automated segmentation of craniopharyngioma on MR images using U-Net-based deep convolutional neural network. Eur Radiol. 2023;33(4):2665\u20132675. doi:10.1007\/s00330-022-09216-1"},{"issue":"5","key":"b51","series-title":"J Magn Reson Imaging","first-page":"1541","article-title":"Machine learning-based multiparametric magnetic resonance imaging radiomic model for discrimination of pathological subtypes of craniopharyngioma","volume":"54","author":"Huang ZS","year":"2021","unstructured":"Huang ZS, Xiao X, Li XD,  Machine learning-based multiparametric magnetic resonance imaging radiomic model for discrimination of pathological subtypes of craniopharyngioma. J Magn Reson Imaging. 2021;54(5):1541\u20131550. doi:10.1002\/jmri.27761"},{"issue":"1","key":"b52","series-title":"Childs Nerv Syst","first-page":"281","article-title":"Limitations of MRI in differentiating solid and cystic components of craniopharyngiomas","volume":"41","author":"Karaalio\u011flu B","year":"2025","unstructured":"Karaalio\u011flu B, \u00d6ks\u00fcz N\u00c7, \u0130pek V, \u00c7ak\u0131r A, Kahraman O, \u00d6zbek MA. Limitations of MRI in differentiating solid and cystic components of craniopharyngiomas. Childs Nerv Syst. 2025;41(1):281. doi:10.1007\/s00381-025-06941-y"},{"issue":"5","key":"b53","series-title":"J Korean Neurosurg Soc","first-page":"466","article-title":"Craniopharyngiomas: radiological differentiation of two types","volume":"59","author":"Lee IH","year":"2016","unstructured":"Lee IH, Zan E, Bell WR, Burger PC, Sung H, Yousem DM. Craniopharyngiomas: radiological differentiation of two types. J Korean Neurosurg Soc. 2016;59(5):466\u2013470. doi:10.3340\/jkns.2016.59.5.466"},{"key":"b54","series-title":"World Neurosurg","first-page":"600","article-title":"First application of 7-T magnetic resonance imaging in endoscopic endonasal surgery of skull base tumors","volume":"103","author":"Barrett TF","year":"2017","unstructured":"Barrett TF, Dyvorne HA, Padormo F,  First application of 7-T magnetic resonance imaging in endoscopic endonasal surgery of skull base tumors. World Neurosurg. 2017;103:600\u2013610. doi:10.1016\/j.wneu.2017.03.088"},{"issue":"4","key":"b55","series-title":"Neuro Oncol","first-page":"506","article-title":"Evaluation of children with craniopharyngioma using carbon-11 methionine PET prior to proton therapy","volume":"15","author":"Laser B","year":"2013","unstructured":"Laser B, Merchant T, Indelicato D, Hua CH, Shulkin B, Snyder S. Evaluation of children with craniopharyngioma using carbon-11 methionine PET prior to proton therapy. Neuro Oncol. 2013;15(4):506\u2013510. doi:10.1093\/neuonc\/nos321"},{"key":"b56","series-title":"World Neurosurg","first-page":"591","article-title":"Preoperative evaluation of sellar and parasellar macrolesions by [18F]fluorodeoxyglucose positron emission tomography","volume":"103","author":"Tosaka M","year":"2017","unstructured":"Tosaka M, Higuchi T, Horiguchi K,  Preoperative evaluation of sellar and parasellar macrolesions by [18F]fluorodeoxyglucose positron emission tomography. World Neurosurg. 2017;103:591\u2013599. doi:10.1016\/j.wneu.2017.04.032"},{"issue":"3","key":"b57","series-title":"Clin Nucl Med","first-page":"245","article-title":"High 18F-FDG uptake in a papillary craniopharyngioma of the third ventricle","volume":"48","author":"Kaida H","year":"2023","unstructured":"Kaida H, Matsukubo Y, Im SW, Kashiwagi N, Ishii K. High 18F-FDG uptake in a papillary craniopharyngioma of the third ventricle. Clin Nucl Med. 2023;48(3):245\u2013247. doi:10.1097\/RLU.0000000000004562"},{"key":"b58","series-title":"Front Oncol","first-page":"709321","article-title":"Development of a nomogram based on preoperative bi-parametric MRI and blood indices for the differentiation between cystic-solid pituitary adenoma and craniopharyngioma","volume":"11","author":"Zhao Z","year":"2021","unstructured":"Zhao Z, Xiao D, Nie C,  Development of a nomogram based on preoperative bi-parametric MRI and blood indices for the differentiation between cystic-solid pituitary adenoma and craniopharyngioma. Front Oncol. 2021;11:709321. doi:10.3389\/fonc.2021.709321"},{"issue":"1","key":"b59","series-title":"BMC Neurol","first-page":"6","article-title":"Noninvasive molecular diagnosis of craniopharyngioma with MRI-based radiomics approach","volume":"19","author":"Chen X","year":"2019","unstructured":"Chen X, Tong Y, Shi Z,  Noninvasive molecular diagnosis of craniopharyngioma with MRI-based radiomics approach. BMC Neurol. 2019;19(1):6. doi:10.1186\/s12883-018-1216-z"},{"issue":"1","key":"b60","series-title":"Neurosurg Rev","first-page":"8","article-title":"Development and validation of a radiomics nomogram for preoperative prediction of BRAFV600E mutation status in adult patients with craniopharyngioma","volume":"48","author":"Qiao N","year":"2024","unstructured":"Qiao N, Li C, Zheng F,  Development and validation of a radiomics nomogram for preoperative prediction of BRAFV600E mutation status in adult patients with craniopharyngioma. Neurosurg Rev. 2024;48(1):8. doi:10.1007\/s10143-024-03170-w"},{"issue":"1","key":"b61","series-title":"Sci Rep","first-page":"16885","article-title":"Robust deep learning classification of adamantinomatous craniopharyngioma from limited preoperative radiographic images","volume":"10","author":"Prince EW","year":"2020","unstructured":"Prince EW, Whelan R, Mirsky DM,  Robust deep learning classification of adamantinomatous craniopharyngioma from limited preoperative radiographic images. Sci Rep. 2020;10(1):16885. doi:10.1038\/s41598-020-73278-8"},{"issue":"12","key":"b62","series-title":"Jpn J Radiol","first-page":"1125","article-title":"Discrimination between pituitary adenoma and craniopharyngioma using MRI-based image features and texture features","volume":"38","author":"Zhang Y","year":"2020","unstructured":"Zhang Y, Chen C, Tian Z, Xu J. Discrimination between pituitary adenoma and craniopharyngioma using MRI-based image features and texture features. Jpn J Radiol. 2020;38(12):1125\u20131134. doi:10.1007\/s11604-020-01021-4"},{"key":"b63","series-title":"Contrast Media Mol Imaging","first-page":"4837156","article-title":"Radiomic analysis of craniopharyngioma and meningioma in the sellar\/parasellar area with MR images features and texture features: a feasible study","volume":"2020","author":"Tian Z","year":"2020","unstructured":"Tian Z, Chen C, Zhang Y, Fan Y, Feng R, Xu J. Radiomic analysis of craniopharyngioma and meningioma in the sellar\/parasellar area with MR images features and texture features: a feasible study. Contrast Media Mol Imaging. 2020;2020:4837156. doi:10.1155\/2020\/4837156"},{"issue":"1","key":"b64","series-title":"J Pers Med","first-page":"45","article-title":"Differentiation between germinoma and craniopharyngioma using radiomics-based machine learning","volume":"12","author":"Chen B","year":"2022","unstructured":"Chen B, Chen C, Zhang Y,  Differentiation between germinoma and craniopharyngioma using radiomics-based machine learning. J Pers Med. 2022;12(1):45. doi:10.3390\/jpm12010045"},{"issue":"1","key":"b65","series-title":"Sci Rep","first-page":"19967","article-title":"Machine learning method based on radiomics help differentiate posterior pituitary tumors from pituitary neuroendocrine tumors and craniopharyngioma","volume":"15","author":"Liu Y","year":"2025","unstructured":"Liu Y, Zhou Y, Zhou C,  Machine learning method based on radiomics help differentiate posterior pituitary tumors from pituitary neuroendocrine tumors and craniopharyngioma. Sci Rep. 2025;15(1):19967. doi:10.1038\/s41598-025-05143-5"},{"issue":"8","key":"b66","series-title":"Childs Nerv Syst","first-page":"2295","article-title":"Diagnostic support in pediatric craniopharyngioma using deep learning","volume":"40","author":"Castiglioni G","year":"2024","unstructured":"Castiglioni G, Vallejos J, Intriago J,  Diagnostic support in pediatric craniopharyngioma using deep learning. Childs Nerv Syst. 2024;40(8):2295\u20132300. doi:10.1007\/s00381-024-06400-0"},{"issue":"1","key":"b67","series-title":"J Craniofac Surg","first-page":"228","article-title":"Multifactor prognostic evaluation of postoperative craniopharyngiomas","volume":"32","author":"Yang F","year":"2021","unstructured":"Yang F, Liu W, Cheng D,  Multifactor prognostic evaluation of postoperative craniopharyngiomas. J Craniofac Surg. 2021;32(1):228\u2013232. doi:10.1097\/SCS.0000000000006910"},{"issue":"14","key":"b68","series-title":"Cancers (Basel)","first-page":"2532","article-title":"Topography and radiological variables as ancillary parameters for evaluating tissue adherence, hypothalamic-pituitary dysfunction, and recurrence in craniopharyngioma: an integrated multidisciplinary overview","volume":"16","author":"Calandrelli R","year":"2024","unstructured":"Calandrelli R, D\u2019Apolito G, Martucci M,  Topography and radiological variables as ancillary parameters for evaluating tissue adherence, hypothalamic-pituitary dysfunction, and recurrence in craniopharyngioma: an integrated multidisciplinary overview. Cancers (Basel). 2024;16(14):2532. doi:10.3390\/cancers16142532"},{"issue":"4","key":"b69","series-title":"Pituitary","first-page":"80","article-title":"FAP as a prognostic biomarker and radiomics-based predictor of angiogenesis-associated recurrence in adamantinomatous craniopharyngioma","volume":"28","author":"Huang Q","year":"2025","unstructured":"Huang Q, Yan X, Zhang B,  FAP as a prognostic biomarker and radiomics-based predictor of angiogenesis-associated recurrence in adamantinomatous craniopharyngioma. Pituitary. 2025;28(4):80. doi:10.1007\/s11102-025-01552-x"},{"issue":"6","key":"b70","series-title":"Diagnostics (Basel)","first-page":"1132","article-title":"Uncertainty-aware deep learning classification of adamantinomatous craniopharyngioma from preoperative MRI","volume":"13","author":"Prince EW","year":"2023","unstructured":"Prince EW, Ghosh D, G\u00f6rg C, Hankinson TC. Uncertainty-aware deep learning classification of adamantinomatous craniopharyngioma from preoperative MRI. Diagnostics (Basel). 2023;13(6):1132. doi:10.3390\/diagnostics13061132"},{"issue":"16","key":"b71","series-title":"Cancers (Basel)","first-page":"2625","article-title":"AI-driven innovations in neuroradiology and neurosurgery: scoping review of current evidence and future directions","volume":"17","author":"Szmyd B","year":"2025","unstructured":"Szmyd B, Podstawka M, Wi\u015bniewski K,  AI-driven innovations in neuroradiology and neurosurgery: scoping review of current evidence and future directions. Cancers (Basel). 2025;17(16):2625. doi:10.3390\/cancers17162625"},{"issue":"6","key":"b72","series-title":"Cancers (Basel)","first-page":"1227","article-title":"Blood-based detection of BRAF V600E in gliomas and brain tumor metastasis","volume":"13","author":"Kang KM","year":"2021","unstructured":"Kang KM, Muralidharan K, Yekula A,  Blood-based detection of BRAF V600E in gliomas and brain tumor metastasis. Cancers (Basel). 2021;13(6):1227. doi:10.3390\/cancers13061227"},{"issue":"51","key":"b73","series-title":"Oncotarget","first-page":"85430","article-title":"Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAF V600 mutated malignancies","volume":"7","author":"Momtaz P","year":"2016","unstructured":"Momtaz P, Pentsova E, Abdel-Wahab O,  Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAF V600 mutated malignancies. Oncotarget. 2016;7(51):85430\u201385436. doi:10.18632\/oncotarget.13397"},{"issue":"1","key":"b1","series-title":"Nat Rev Dis Primers","first-page":"75","article-title":"Craniopharyngioma","volume":"5","author":"M\u00fcller HL","year":"2019","unstructured":"M\u00fcller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S. Craniopharyngioma. Nat Rev Dis Primers. 2019;5(1):75. doi:10.1038\/s41572-019-0125-9"},{"issue":"4","key":"b2","series-title":"Neurosurgery","first-page":"631","article-title":"Adult craniopharyngioma: case series, systematic review, and meta-analysis","volume":"83","author":"Dandurand C","year":"2018","unstructured":"Dandurand C, Sepehry AA, Asadi Lari MH, Akagami R, Gooderham P. Adult craniopharyngioma: case series, systematic review, and meta-analysis. Neurosurgery. 2018;83(4):631\u2013641. doi:10.1093\/neuros\/nyx570"},{"issue":"3","key":"b3","series-title":"Endocr Rev","first-page":"518","article-title":"Contemporary biological insights and clinical management of craniopharyngioma","volume":"44","author":"Apps JR","year":"2023","unstructured":"Apps JR, Muller HL, Hankinson TC, Yock TI, Martinez-Barbera JP. Contemporary biological insights and clinical management of craniopharyngioma. Endocr Rev. 2023;44(3):518\u2013538. doi:10.1210\/endrev\/bnac035"},{"issue":"11","key":"b4","series-title":"Heliyon","first-page":"e32112","article-title":"Craniopharyngioma: a comprehensive review of the clinical presentation, radiological findings, management, and future perspective","volume":"10","author":"Alboqami MN","year":"2024","unstructured":"Alboqami MN, Khalid S Albaiahy A, Bukhari BH,  Craniopharyngioma: a comprehensive review of the clinical presentation, radiological findings, management, and future perspective. Heliyon. 2024;10(11):e32112. doi:10.1016\/j.heliyon.2024.e32112"},{"issue":"2","key":"b5","series-title":"Nat Genet","first-page":"161","article-title":"Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas","volume":"46","author":"Brastianos PK","year":"2014","unstructured":"Brastianos PK, Taylor-Weiner A, Manley PE,  Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet. 2014;46(2):161\u2013165. doi:10.1038\/ng.2868"},{"issue":"6","key":"b6","series-title":"Acta Neuropathol","first-page":"589","article-title":"Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region","volume":"109","author":"Buslei R","year":"2005","unstructured":"Buslei R, Nolde M, Hofmann B,  Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol. 2005;109(6):589\u2013597. doi:10.1007\/s00401-005-1004-x"},{"issue":"5","key":"b7","series-title":"Pituitary","first-page":"544","article-title":"Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor","volume":"19","author":"Aylwin SJB","year":"2016","unstructured":"Aylwin SJB, Bodi I, Beaney R. Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor. Pituitary. 2016;19(5):544\u2013546. doi:10.1007\/s11102-015-0663-4"},{"issue":"4","key":"b8","series-title":"Pituitary","first-page":"482","article-title":"Dabrafenib as a diagnostic and therapeutic strategy for the non-surgical management of papillary craniopharyngioma","volume":"26","author":"Lin AL","year":"2023","unstructured":"Lin AL, Tabar V, Young RJ, Geer EB. Dabrafenib as a diagnostic and therapeutic strategy for the non-surgical management of papillary craniopharyngioma. Pituitary. 2023;26(4):482\u2013487. doi:10.1007\/s11102-023-01339-y"},{"issue":"2","key":"b9","series-title":"N Engl J Med","first-page":"118","article-title":"BRAF-MEK inhibition in newly diagnosed papillary craniopharyngiomas","volume":"389","author":"Brastianos PK","year":"2023","unstructured":"Brastianos PK, Twohy E, Geyer S,  BRAF-MEK inhibition in newly diagnosed papillary craniopharyngiomas. N Engl J Med. 2023;389(2):118\u2013126. doi:10.1056\/NEJMoa2213329"},{"key":"b10","series-title":"Front Oncol","first-page":"791","article-title":"Targeting IL-6 is a potential treatment for primary cystic craniopharyngioma","volume":"9","author":"Grob S","year":"2019","unstructured":"Grob S, Mirsky DM, Donson AM,  Targeting IL-6 is a potential treatment for primary cystic craniopharyngioma. Front Oncol. 2019;9:791. doi:10.3389\/fonc.2019.00791"},{"issue":"6","key":"b11","series-title":"Ann Endocrinol (Paris)","first-page":"727","article-title":"First evidence of anti-VEGF efficacy in an adult case of adamantinomatous craniopharyngioma: case report and illustrative review","volume":"84","author":"De Rosa A","year":"2023","unstructured":"De Rosa A, Calvanese F, Ducray F,  First evidence of anti-VEGF efficacy in an adult case of adamantinomatous craniopharyngioma: case report and illustrative review. Ann Endocrinol (Paris). 2023;84(6):727\u2013733. doi:10.1016\/j.ando.2023.10.003"},{"issue":"3","key":"b12","series-title":"Pediatr Blood Cancer","first-page":"e28753","article-title":"Radiologic response to MEK inhibition in a patient with a WNT-activated craniopharyngioma","volume":"68","author":"Patel K","year":"2021","unstructured":"Patel K, Allen J, Zagzag D,  Radiologic response to MEK inhibition in a patient with a WNT-activated craniopharyngioma. Pediatr Blood Cancer. 2021;68(3):e28753. doi:10.1002\/pbc.28753"},{"issue":"4","key":"b13","series-title":"Eur J Endocrinol","first-page":"R139","article-title":"Endocrine tumors: BRAF V600E mutations in papillary craniopharyngioma","volume":"174","author":"Brastianos PK","year":"2016","unstructured":"Brastianos PK, Santagata S. Endocrine tumors: BRAF V600E mutations in papillary craniopharyngioma. Eur J Endocrinol. 2016;174(4):R139\u2013R144. doi:10.1530\/EJE-15-0957"},{"key":"b14","series-title":"Front Endocrinol (Lausanne)","first-page":"1562942","article-title":"Recent advances in craniopharyngioma pathophysiology and emerging therapeutic approaches","volume":"16","author":"Pires de Oliveira Neto C","year":"2025","unstructured":"Pires de Oliveira Neto C, Nascimento GC, Damianse SDSP, Faria MDS. Recent advances in craniopharyngioma pathophysiology and emerging therapeutic approaches. Front Endocrinol (Lausanne). 2025;16:1562942. doi:10.3389\/fendo.2025.1562942"},{"issue":"6","key":"b15","series-title":"Neurosurg Focus","first-page":"E2","article-title":"Diagnosis and management of craniopharyngiomas in the era of genomics and targeted therapy","volume":"41","author":"Martinez-Gutierrez JC","year":"2016","unstructured":"Martinez-Gutierrez JC, D\u2019Andrea MR, Cahill DP, Santagata S, Barker FG, Brastianos PK. Diagnosis and management of craniopharyngiomas in the era of genomics and targeted therapy. Neurosurg Focus. 2016;41(6):E2. doi:10.3171\/2016.9.FOCUS16325"},{"key":"b16","series-title":"Front Neurol","first-page":"752119","article-title":"Application of artificial intelligence in diagnosis of craniopharyngioma","volume":"12","author":"Qin C","year":"2021","unstructured":"Qin C, Hu W, Wang X, Ma X. Application of artificial intelligence in diagnosis of craniopharyngioma. Front Neurol. 2021;12:752119. doi:10.3389\/fneur.2021.752119"},{"key":"b17","series-title":"World Neurosurg","first-page":"601","article-title":"Creative and innovative methods and techniques for the challenges in the management of adult craniopharyngioma","volume":"142","author":"Takami H","year":"2020","unstructured":"Takami H, Vel\u00e1squez C, Asha MJ, Oswari S, Almeida JP, Gentili F. Creative and innovative methods and techniques for the challenges in the management of adult craniopharyngioma. World Neurosurg. 2020;142:601\u2013610. doi:10.1016\/j.wneu.2020.05.173"},{"issue":"2","key":"b18","series-title":"J Clin Med","first-page":"519","article-title":"The inflammatory milieu of adamantinomatous craniopharyngioma and its implications for treatment","volume":"9","author":"Whelan R","year":"2020","unstructured":"Whelan R, Prince E, Gilani A, Hankinson T. The inflammatory milieu of adamantinomatous craniopharyngioma and its implications for treatment. J Clin Med. 2020;9(2):519. doi:10.3390\/jcm9020519"},{"key":"b19","series-title":"World Neurosurg","first-page":"124414","article-title":"Targeted therapy for recurrent and refractory papillary craniopharyngioma: a systematic narrative review","volume":"202","author":"Lin Y","year":"2025","unstructured":"Lin Y, Luo N, Zhang B, An W, Lin Z. Targeted therapy for recurrent and refractory papillary craniopharyngioma: a systematic narrative review. World Neurosurg. 2025;202:124414. doi:10.1016\/j.wneu.2025.124414"},{"issue":"7","key":"b20","series-title":"Head Neck","first-page":"1036","article-title":"Craniopharyngioma: a pathologic, clinical, and surgical review","volume":"34","author":"Fernandez-Miranda JC","year":"2012","unstructured":"Fernandez-Miranda JC, Gardner PA, Snyderman CH,  Craniopharyngioma: a pathologic, clinical, and surgical review. Head Neck. 2012;34(7):1036\u20131044. doi:10.1002\/hed.21771"},{"key":"b21","article-title":"Central Nervous System Tumours: WHO Classification of Tumours","year":"2021","unstructured":"Central Nervous System Tumours: WHO Classification of Tumours. 5th ed. World Health Organization;2021."},{"key":"b22","series-title":"F1000Res","first-page":"1202","article-title":"Recent advances in molecular pathology of craniopharyngioma","volume":"6","author":"Larkin S","year":"2017","unstructured":"Larkin S, Karavitaki N. Recent advances in molecular pathology of craniopharyngioma. F1000Res. 2017;6:1202. doi:10.12688\/f1000research.11549.1"},{"issue":"5","key":"b23","series-title":"Acta Neuropathol","first-page":"757","article-title":"Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK\/ERK pathway as a novel therapeutic target","volume":"135","author":"Apps JR","year":"2018","unstructured":"Apps JR, Carreno G, Gonzalez-Meljem JM,  Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK\/ERK pathway as a novel therapeutic target. Acta Neuropathol. 2018;135(5):757\u2013777. doi:10.1007\/s00401-018-1830-2"},{"issue":"5","key":"b24","series-title":"Neuro Oncol","first-page":"1180","article-title":"Molecular subtypes of adamantinomatous craniopharyngiomas","volume":"27","author":"An W","year":"2025","unstructured":"An W, Li S, An Y, Lin Z. Molecular subtypes of adamantinomatous craniopharyngiomas. Neuro Oncol. 2025;27(5):1180\u20131192. doi:10.1093\/neuonc\/noaf030"},{"issue":"18","key":"b25","series-title":"ACS Chem Neurosci","first-page":"3347","article-title":"Transcription factor GLI1 induces IL-6-mediated inflammatory response and facilitates the progression of adamantinomatous craniopharyngioma","volume":"14","author":"Zhao J","year":"2023","unstructured":"Zhao J, Yang Y, Pan Y,  Transcription factor GLI1 induces IL-6-mediated inflammatory response and facilitates the progression of adamantinomatous craniopharyngioma. ACS Chem Neurosci. 2023;14(18):3347\u20133356. doi:10.1021\/acschemneuro.3c00031"},{"issue":"5","key":"b26","series-title":"J Neurosurg","first-page":"1473","article-title":"Do craniopharyngioma molecular signatures correlate with clinical characteristics?","volume":"128","author":"Omay SB","year":"2018","unstructured":"Omay SB, Chen YN, Almeida JP,  Do craniopharyngioma molecular signatures correlate with clinical characteristics?. J Neurosurg. 2018;128(5):1473\u20131478. doi:10.3171\/2017.1.JNS162232"},{"issue":"4","key":"b27","series-title":"Brain Tumor Pathol","first-page":"130","article-title":"Comprehensive molecular characterization of craniopharyngiomas using whole transcriptome and spatial transcriptomics approaches","volume":"42","author":"Kert \u0160","year":"2025","unstructured":"Kert \u0160, Matja\u0161i\u010d A, Pi\u017eem J,  Comprehensive molecular characterization of craniopharyngiomas using whole transcriptome and spatial transcriptomics approaches. Brain Tumor Pathol. 2025;42(4):130\u2013142. doi:10.1007\/s10014-025-00509-z"},{"issue":"6","key":"b28","series-title":"Pituitary","first-page":"905","article-title":"Targeted BRAF and CTNNB1 next-generation sequencing allows proper classification of nonadenomatous lesions of the sellar region in samples with limiting amounts of lesional cells","volume":"18","author":"Marucci G","year":"2015","unstructured":"Marucci G, de Biase D, Zoli M,  Targeted BRAF and CTNNB1 next-generation sequencing allows proper classification of nonadenomatous lesions of the sellar region in samples with limiting amounts of lesional cells. Pituitary. 2015;18(6):905\u2013911. doi:10.1007\/s11102-015-0669-y"},{"issue":"3","key":"b29","series-title":"JAMA Oncol","first-page":"317","article-title":"Molecular testing for the World Health Organization Classification of Central Nervous System Tumors: a review","volume":"11","author":"Horbinski C","year":"2025","unstructured":"Horbinski C, Solomon DA, Lukas RV,  Molecular testing for the World Health Organization Classification of Central Nervous System Tumors: a review. JAMA Oncol. 2025;11(3):317\u2013328. doi:10.1001\/jamaoncol.2024.5506"},{"issue":"1","key":"b30","series-title":"Signal Transduct Target Ther","first-page":"3","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu J","year":"2022","unstructured":"Liu J, Xiao Q, Xiao J,  Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7(1):3. doi:10.1038\/s41392-021-00762-6"},{"issue":"Supplement_5","key":"b31","series-title":"Neuro Oncol","first-page":"v127","article-title":"CTNI-10. A phase 1\/2 trial of FOG-001, a first-in-class direct \u03b2-Catenin:TCF4 inhibitor: safety and preliminary antitumor activity in adamantinomatous craniopharyngioma (ACP) patients","volume":"27","author":"Papadopoulos KP","year":"2025","unstructured":"Papadopoulos KP, Brastianos PK, Cecchini M,  CTNI-10. A phase 1\/2 trial of FOG-001, a first-in-class direct \u03b2-Catenin:TCF4 inhibitor: safety and preliminary antitumor activity in adamantinomatous craniopharyngioma (ACP) patients. Neuro Oncol. 2025;27(Supplement_5):v127. doi:10.1093\/neuonc\/noaf201.0507"},{"issue":"4","key":"b32","series-title":"Endocrinol Metab Clin North Am","first-page":"703","article-title":"Pathogenesis of craniopharyngiomas and targeted approaches to therapy","volume":"54","author":"Gritsch S","year":"2025","unstructured":"Gritsch S, Brastianos PK. Pathogenesis of craniopharyngiomas and targeted approaches to therapy. Endocrinol Metab Clin North Am. 2025;54(4):703\u2013714. doi:10.1016\/j.ecl.2025.06.006"},{"key":"b33","series-title":"Front Oncol","first-page":"735778","article-title":"Diagnostic value of non-contrast CT in cerebrospinal fluid leakage after endoscopic transnasal surgery for sellar and suprasellar tumors","volume":"11","author":"Gao W","year":"2021","unstructured":"Gao W, Wang X, Fang Y,  Diagnostic value of non-contrast CT in cerebrospinal fluid leakage after endoscopic transnasal surgery for sellar and suprasellar tumors. Front Oncol. 2021;11:735778. doi:10.3389\/fonc.2021.735778"},{"issue":"1","key":"b34","series-title":"Clin Epigenetics","first-page":"87","article-title":"Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluid","volume":"16","author":"Cornelli L","year":"2024","unstructured":"Cornelli L, Van Paemel R, Ferro Dos Santos MR,  Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluid. Clin Epigenetics. 2024;16(1):87. doi:10.1186\/s13148-024-01696-w"},{"issue":"4","key":"b35","series-title":"Mod Pathol","first-page":"596","article-title":"Cross-reactivity of the BRAF VE1 antibody with epitopes in axonemal dyneins leads to staining of cilia","volume":"28","author":"Jones RT","year":"2015","unstructured":"Jones RT, Abedalthagafi MS, Brahmandam M,  Cross-reactivity of the BRAF VE1 antibody with epitopes in axonemal dyneins leads to staining of cilia. Mod Pathol. 2015;28(4):596\u2013606. doi:10.1038\/modpathol.2014.150"},{"issue":"6","key":"b36","series-title":"Am J Clin Pathol","first-page":"811","article-title":"VE1 antibody immunoreactivity in normal anterior pituitary and adrenal cortex without detectable BRAF V600E mutations","volume":"141","author":"Mordes DA","year":"2014","unstructured":"Mordes DA, Lynch K, Campbell S,  VE1 antibody immunoreactivity in normal anterior pituitary and adrenal cortex without detectable BRAF V600E mutations. Am J Clin Pathol. 2014;141(6):811\u2013815. doi:10.1309\/AJCP37TLZLTUAOJL"},{"issue":"1","key":"b37","series-title":"Neurosurg Rev","first-page":"41","article-title":"Histopathological and molecular predictors of growth patterns and recurrence in craniopharyngiomas: a systematic review","volume":"43","author":"Coury JR","year":"2020","unstructured":"Coury JR, Davis BN, Koumas CP, Manzano GS, Dehdashti AR. Histopathological and molecular predictors of growth patterns and recurrence in craniopharyngiomas: a systematic review. Neurosurg Rev. 2020;43(1):41\u201348. doi:10.1007\/s10143-018-0978-5"},{"issue":"1","key":"b38","series-title":"J Exp Clin Cancer Res","first-page":"95","article-title":"Can recurrences be predicted in craniopharyngiomas? \u03b2-catenin coexisting with stem cells markers and p-ATM in a clinicopathologic study of 45cases","volume":"36","author":"Guadagno E","year":"2017","unstructured":"Guadagno E, de Divitiis O, Solari D,  Can recurrences be predicted in craniopharyngiomas? \u03b2-catenin coexisting with stem cells markers and p-ATM in a clinicopathologic study of 45cases. J Exp Clin Cancer Res. 2017;36(1):95. doi:10.1186\/s13046-017-0562-9"},{"issue":"12","key":"b39","series-title":"Neurochem Res","first-page":"2346","article-title":"Expression of matrix metalloproteinase-9, type IV collagen and vascular endothelial growth factor in adamantinous craniopharyngioma","volume":"36","author":"Xia Z","year":"2011","unstructured":"Xia Z, Liu W, Li S,  Expression of matrix metalloproteinase-9, type IV collagen and vascular endothelial growth factor in adamantinous craniopharyngioma. Neurochem Res. 2011;36(12):2346\u20132351. doi:10.1007\/s11064-011-0560-9"},{"issue":"7","key":"b40","series-title":"Childs Nerv Syst","first-page":"1461","article-title":"Ki67 as a prognostic factor of craniopharyngioma\u2019s recurrence in paediatric population","volume":"36","author":"Moszczy\u0144ska E","year":"2020","unstructured":"Moszczy\u0144ska E, Prokop-Piotrkowska M, Bogusz-W\u00f3jcik A, Grajkowska W, Szyma\u0144ska S, Szalecki M. Ki67 as a prognostic factor of craniopharyngioma\u2019s recurrence in paediatric population. Childs Nerv Syst. 2020;36(7):1461\u20131469. doi:10.1007\/s00381-020-04519-4"},{"issue":"24","key":"b41","series-title":"J Clin Med","first-page":"7481","article-title":"Pathological diagnosis of adult craniopharyngioma on MR images: an automated end-to-end approach based on deep neural networks requiring no manual segmentation","volume":"11","author":"Teng Y","year":"2022","unstructured":"Teng Y, Ran X, Chen B, Chen C, Xu J. Pathological diagnosis of adult craniopharyngioma on MR images: an automated end-to-end approach based on deep neural networks requiring no manual segmentation. J Clin Med. 2022;11(24):7481. doi:10.3390\/jcm11247481"},{"key":"b42","series-title":"Clin Neurol Neurosurg","first-page":"106347","article-title":"Prediction of CTNNB1 mutation status in pediatric cystic adamantinomatous craniopharyngioma by using preoperative magnetic resonance imaging manifestation","volume":"200","author":"Zhu W","year":"2021","unstructured":"Zhu W, Tang T, Yuan S, Chang B, Li S, Chen M. Prediction of CTNNB1 mutation status in pediatric cystic adamantinomatous craniopharyngioma by using preoperative magnetic resonance imaging manifestation. Clin Neurol Neurosurg. 2021;200:106347. doi:10.1016\/j.clineuro.2020.106347"},{"issue":"1","key":"b43","series-title":"Acta Med Litu","first-page":"68","article-title":"Imaging and MR spectroscopy in papillary craniopharyngioma","volume":"31","author":"Mahajan A","year":"2024","unstructured":"Mahajan A, Charan BD, Agarwal S,  Imaging and MR spectroscopy in papillary craniopharyngioma. Acta Med Litu. 2024;31(1):68\u201374. doi:10.15388\/Amed.2024.31.1.10"},{"issue":"15","key":"b44","series-title":"Cancers (Basel)","first-page":"3831","article-title":"The challenging management of craniopharyngiomas in adults: time for a reappraisal?","volume":"14","author":"Cuny T","year":"2022","unstructured":"Cuny T, Buchfelder M, Dufour H,  The challenging management of craniopharyngiomas in adults: time for a reappraisal?. Cancers (Basel). 2022;14(15):3831. doi:10.3390\/cancers14153831"},{"key":"b45","series-title":"Neoplasia","first-page":"101060","article-title":"Distinction of papillary and adamantinomatous craniopharyngioma: clinical features, surgical nuances and hypothalamic outcomes","volume":"57","author":"Yang L","year":"2024","unstructured":"Yang L, Liu Y, Wang C,  Distinction of papillary and adamantinomatous craniopharyngioma: clinical features, surgical nuances and hypothalamic outcomes. Neoplasia. 2024;57:101060. doi:10.1016\/j.neo.2024.101060"},{"issue":"1","key":"b46","series-title":"J Neurosurg","first-page":"27","article-title":"Prediction of BRAF mutation status of craniopharyngioma using magnetic resonance imaging features","volume":"129","author":"Yue Q","year":"2018","unstructured":"Yue Q, Yu Y, Shi Z,  Prediction of BRAF mutation status of craniopharyngioma using magnetic resonance imaging features. J Neurosurg. 2018;129(1):27\u201334. doi:10.3171\/2017.4.JNS163113"},{"issue":"2","key":"b47","series-title":"Neurosurgery","first-page":"204","article-title":"A clinical rule for preoperative prediction of BRAF mutation status in craniopharyngiomas","volume":"85","author":"Fujio S","year":"2019","unstructured":"Fujio S, Juratli TA, Arita K,  A clinical rule for preoperative prediction of BRAF mutation status in craniopharyngiomas. Neurosurgery. 2019;85(2):204\u2013210. doi:10.1093\/neuros\/nyy569"},{"issue":"5","key":"b48","series-title":"Neuroradiology","first-page":"1313","article-title":"Tumor features in adult papillary and adamantinomatous craniopharyngioma: neuroradiological evaluation of pituitary-hypothalamic-axis dysfunction and outcome prediction","volume":"67","author":"Calandrelli R","year":"2025","unstructured":"Calandrelli R, Pilato F, D\u2019Apolito G,  Tumor features in adult papillary and adamantinomatous craniopharyngioma: neuroradiological evaluation of pituitary-hypothalamic-axis dysfunction and outcome prediction. Neuroradiology. 2025;67(5):1313\u20131327. doi:10.1007\/s00234-025-03615-z"},{"issue":"3","key":"b49","series-title":"J Neurol Surg Rep","first-page":"e121","article-title":"Pathological and topographical classification of craniopharyngiomas: a literature review","volume":"77","author":"Lubuulwa J","year":"2016","unstructured":"Lubuulwa J, Lei T. Pathological and topographical classification of craniopharyngiomas: a literature review. J Neurol Surg Rep. 2016;77(3):e121\u2013e127. doi:10.1055\/s-0036-1588060"},{"issue":"4","key":"b50","series-title":"Eur Radiol","first-page":"2665","article-title":"Automated segmentation of craniopharyngioma on MR images using U-Net-based deep convolutional neural network","volume":"33","author":"Chen C","year":"2023","unstructured":"Chen C, Zhang T, Teng Y,  Automated segmentation of craniopharyngioma on MR images using U-Net-based deep convolutional neural network. Eur Radiol. 2023;33(4):2665\u20132675. doi:10.1007\/s00330-022-09216-1"},{"issue":"5","key":"b51","series-title":"J Magn Reson Imaging","first-page":"1541","article-title":"Machine learning-based multiparametric magnetic resonance imaging radiomic model for discrimination of pathological subtypes of craniopharyngioma","volume":"54","author":"Huang ZS","year":"2021","unstructured":"Huang ZS, Xiao X, Li XD,  Machine learning-based multiparametric magnetic resonance imaging radiomic model for discrimination of pathological subtypes of craniopharyngioma. J Magn Reson Imaging. 2021;54(5):1541\u20131550. doi:10.1002\/jmri.27761"},{"issue":"1","key":"b52","series-title":"Childs Nerv Syst","first-page":"281","article-title":"Limitations of MRI in differentiating solid and cystic components of craniopharyngiomas","volume":"41","author":"Karaalio\u011flu B","year":"2025","unstructured":"Karaalio\u011flu B, \u00d6ks\u00fcz N\u00c7, \u0130pek V, \u00c7ak\u0131r A, Kahraman O, \u00d6zbek MA. Limitations of MRI in differentiating solid and cystic components of craniopharyngiomas. Childs Nerv Syst. 2025;41(1):281. doi:10.1007\/s00381-025-06941-y"},{"issue":"5","key":"b53","series-title":"J Korean Neurosurg Soc","first-page":"466","article-title":"Craniopharyngiomas: radiological differentiation of two types","volume":"59","author":"Lee IH","year":"2016","unstructured":"Lee IH, Zan E, Bell WR, Burger PC, Sung H, Yousem DM. Craniopharyngiomas: radiological differentiation of two types. J Korean Neurosurg Soc. 2016;59(5):466\u2013470. doi:10.3340\/jkns.2016.59.5.466"},{"key":"b54","series-title":"World Neurosurg","first-page":"600","article-title":"First application of 7-T magnetic resonance imaging in endoscopic endonasal surgery of skull base tumors","volume":"103","author":"Barrett TF","year":"2017","unstructured":"Barrett TF, Dyvorne HA, Padormo F,  First application of 7-T magnetic resonance imaging in endoscopic endonasal surgery of skull base tumors. World Neurosurg. 2017;103:600\u2013610. doi:10.1016\/j.wneu.2017.03.088"},{"issue":"4","key":"b55","series-title":"Neuro Oncol","first-page":"506","article-title":"Evaluation of children with craniopharyngioma using carbon-11 methionine PET prior to proton therapy","volume":"15","author":"Laser B","year":"2013","unstructured":"Laser B, Merchant T, Indelicato D, Hua CH, Shulkin B, Snyder S. Evaluation of children with craniopharyngioma using carbon-11 methionine PET prior to proton therapy. Neuro Oncol. 2013;15(4):506\u2013510. doi:10.1093\/neuonc\/nos321"},{"key":"b56","series-title":"World Neurosurg","first-page":"591","article-title":"Preoperative evaluation of sellar and parasellar macrolesions by [18F]fluorodeoxyglucose positron emission tomography","volume":"103","author":"Tosaka M","year":"2017","unstructured":"Tosaka M, Higuchi T, Horiguchi K,  Preoperative evaluation of sellar and parasellar macrolesions by [18F]fluorodeoxyglucose positron emission tomography. World Neurosurg. 2017;103:591\u2013599. doi:10.1016\/j.wneu.2017.04.032"},{"issue":"3","key":"b57","series-title":"Clin Nucl Med","first-page":"245","article-title":"High 18F-FDG uptake in a papillary craniopharyngioma of the third ventricle","volume":"48","author":"Kaida H","year":"2023","unstructured":"Kaida H, Matsukubo Y, Im SW, Kashiwagi N, Ishii K. High 18F-FDG uptake in a papillary craniopharyngioma of the third ventricle. Clin Nucl Med. 2023;48(3):245\u2013247. doi:10.1097\/RLU.0000000000004562"},{"key":"b58","series-title":"Front Oncol","first-page":"709321","article-title":"Development of a nomogram based on preoperative bi-parametric MRI and blood indices for the differentiation between cystic-solid pituitary adenoma and craniopharyngioma","volume":"11","author":"Zhao Z","year":"2021","unstructured":"Zhao Z, Xiao D, Nie C,  Development of a nomogram based on preoperative bi-parametric MRI and blood indices for the differentiation between cystic-solid pituitary adenoma and craniopharyngioma. Front Oncol. 2021;11:709321. doi:10.3389\/fonc.2021.709321"},{"issue":"1","key":"b59","series-title":"BMC Neurol","first-page":"6","article-title":"Noninvasive molecular diagnosis of craniopharyngioma with MRI-based radiomics approach","volume":"19","author":"Chen X","year":"2019","unstructured":"Chen X, Tong Y, Shi Z,  Noninvasive molecular diagnosis of craniopharyngioma with MRI-based radiomics approach. BMC Neurol. 2019;19(1):6. doi:10.1186\/s12883-018-1216-z"},{"issue":"1","key":"b60","series-title":"Neurosurg Rev","first-page":"8","article-title":"Development and validation of a radiomics nomogram for preoperative prediction of BRAFV600E mutation status in adult patients with craniopharyngioma","volume":"48","author":"Qiao N","year":"2024","unstructured":"Qiao N, Li C, Zheng F,  Development and validation of a radiomics nomogram for preoperative prediction of BRAFV600E mutation status in adult patients with craniopharyngioma. Neurosurg Rev. 2024;48(1):8. doi:10.1007\/s10143-024-03170-w"},{"issue":"1","key":"b61","series-title":"Sci Rep","first-page":"16885","article-title":"Robust deep learning classification of adamantinomatous craniopharyngioma from limited preoperative radiographic images","volume":"10","author":"Prince EW","year":"2020","unstructured":"Prince EW, Whelan R, Mirsky DM,  Robust deep learning classification of adamantinomatous craniopharyngioma from limited preoperative radiographic images. Sci Rep. 2020;10(1):16885. doi:10.1038\/s41598-020-73278-8"},{"issue":"12","key":"b62","series-title":"Jpn J Radiol","first-page":"1125","article-title":"Discrimination between pituitary adenoma and craniopharyngioma using MRI-based image features and texture features","volume":"38","author":"Zhang Y","year":"2020","unstructured":"Zhang Y, Chen C, Tian Z, Xu J. Discrimination between pituitary adenoma and craniopharyngioma using MRI-based image features and texture features. Jpn J Radiol. 2020;38(12):1125\u20131134. doi:10.1007\/s11604-020-01021-4"},{"key":"b63","series-title":"Contrast Media Mol Imaging","first-page":"4837156","article-title":"Radiomic analysis of craniopharyngioma and meningioma in the sellar\/parasellar area with MR images features and texture features: a feasible study","volume":"2020","author":"Tian Z","year":"2020","unstructured":"Tian Z, Chen C, Zhang Y, Fan Y, Feng R, Xu J. Radiomic analysis of craniopharyngioma and meningioma in the sellar\/parasellar area with MR images features and texture features: a feasible study. Contrast Media Mol Imaging. 2020;2020:4837156. doi:10.1155\/2020\/4837156"},{"issue":"1","key":"b64","series-title":"J Pers Med","first-page":"45","article-title":"Differentiation between germinoma and craniopharyngioma using radiomics-based machine learning","volume":"12","author":"Chen B","year":"2022","unstructured":"Chen B, Chen C, Zhang Y,  Differentiation between germinoma and craniopharyngioma using radiomics-based machine learning. J Pers Med. 2022;12(1):45. doi:10.3390\/jpm12010045"},{"issue":"1","key":"b65","series-title":"Sci Rep","first-page":"19967","article-title":"Machine learning method based on radiomics help differentiate posterior pituitary tumors from pituitary neuroendocrine tumors and craniopharyngioma","volume":"15","author":"Liu Y","year":"2025","unstructured":"Liu Y, Zhou Y, Zhou C,  Machine learning method based on radiomics help differentiate posterior pituitary tumors from pituitary neuroendocrine tumors and craniopharyngioma. Sci Rep. 2025;15(1):19967. doi:10.1038\/s41598-025-05143-5"},{"issue":"8","key":"b66","series-title":"Childs Nerv Syst","first-page":"2295","article-title":"Diagnostic support in pediatric craniopharyngioma using deep learning","volume":"40","author":"Castiglioni G","year":"2024","unstructured":"Castiglioni G, Vallejos J, Intriago J,  Diagnostic support in pediatric craniopharyngioma using deep learning. Childs Nerv Syst. 2024;40(8):2295\u20132300. doi:10.1007\/s00381-024-06400-0"},{"issue":"1","key":"b67","series-title":"J Craniofac Surg","first-page":"228","article-title":"Multifactor prognostic evaluation of postoperative craniopharyngiomas","volume":"32","author":"Yang F","year":"2021","unstructured":"Yang F, Liu W, Cheng D,  Multifactor prognostic evaluation of postoperative craniopharyngiomas. J Craniofac Surg. 2021;32(1):228\u2013232. doi:10.1097\/SCS.0000000000006910"},{"issue":"14","key":"b68","series-title":"Cancers (Basel)","first-page":"2532","article-title":"Topography and radiological variables as ancillary parameters for evaluating tissue adherence, hypothalamic-pituitary dysfunction, and recurrence in craniopharyngioma: an integrated multidisciplinary overview","volume":"16","author":"Calandrelli R","year":"2024","unstructured":"Calandrelli R, D\u2019Apolito G, Martucci M,  Topography and radiological variables as ancillary parameters for evaluating tissue adherence, hypothalamic-pituitary dysfunction, and recurrence in craniopharyngioma: an integrated multidisciplinary overview. Cancers (Basel). 2024;16(14):2532. doi:10.3390\/cancers16142532"},{"issue":"4","key":"b69","series-title":"Pituitary","first-page":"80","article-title":"FAP as a prognostic biomarker and radiomics-based predictor of angiogenesis-associated recurrence in adamantinomatous craniopharyngioma","volume":"28","author":"Huang Q","year":"2025","unstructured":"Huang Q, Yan X, Zhang B,  FAP as a prognostic biomarker and radiomics-based predictor of angiogenesis-associated recurrence in adamantinomatous craniopharyngioma. Pituitary. 2025;28(4):80. doi:10.1007\/s11102-025-01552-x"},{"issue":"6","key":"b70","series-title":"Diagnostics (Basel)","first-page":"1132","article-title":"Uncertainty-aware deep learning classification of adamantinomatous craniopharyngioma from preoperative MRI","volume":"13","author":"Prince EW","year":"2023","unstructured":"Prince EW, Ghosh D, G\u00f6rg C, Hankinson TC. Uncertainty-aware deep learning classification of adamantinomatous craniopharyngioma from preoperative MRI. Diagnostics (Basel). 2023;13(6):1132. doi:10.3390\/diagnostics13061132"},{"issue":"16","key":"b71","series-title":"Cancers (Basel)","first-page":"2625","article-title":"AI-driven innovations in neuroradiology and neurosurgery: scoping review of current evidence and future directions","volume":"17","author":"Szmyd B","year":"2025","unstructured":"Szmyd B, Podstawka M, Wi\u015bniewski K,  AI-driven innovations in neuroradiology and neurosurgery: scoping review of current evidence and future directions. Cancers (Basel). 2025;17(16):2625. doi:10.3390\/cancers17162625"},{"issue":"6","key":"b72","series-title":"Cancers (Basel)","first-page":"1227","article-title":"Blood-based detection of BRAF V600E in gliomas and brain tumor metastasis","volume":"13","author":"Kang KM","year":"2021","unstructured":"Kang KM, Muralidharan K, Yekula A,  Blood-based detection of BRAF V600E in gliomas and brain tumor metastasis. Cancers (Basel). 2021;13(6):1227. doi:10.3390\/cancers13061227"},{"issue":"51","key":"b73","series-title":"Oncotarget","first-page":"85430","article-title":"Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAF V600 mutated malignancies","volume":"7","author":"Momtaz P","year":"2016","unstructured":"Momtaz P, Pentsova E, Abdel-Wahab O,  Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAF V600 mutated malignancies. Oncotarget. 2016;7(51):85430\u201385436. doi:10.18632\/oncotarget.13397"}],"container-title":["Neurosurgical Focus"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/60\/6\/article-pE12.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/60\/6\/article-pE12.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/60\/6\/article-pE12.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:32Z","timestamp":1780444832000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/60\/6\/article-pE12.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":146,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3171\/2026.2.focus251109","relation":{},"ISSN":["1092-0684"],"issn-type":[{"value":"1092-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}